Meridian seals the fever file even as a third charter sells out

MERIDIAN — Ask who ages first, and this week the answer bought a ticket.

The longevity directorate here released forty-one pages of the disputed fever record to the Charter Court and Earth's longevity therapy board, then redacted nine of them. Then it declined, for the fourth time, to hand over the full patient dataset. Within a week, the colony's third therapy charter sold its last of one hundred and thirty-nine berths. Departure is sixty-one days out.

The file concerns one retired desalination engineer, part of a first cohort of one hundred and forty. The other one hundred and thirty-nine came home without complication. The engineer developed a transient fever of unexplained origin, and it resolved on its own. Days ago, a second cohort of one hundred and thirty-nine returned with clean markers and no sealed files. Two charters, two hundred and seventy-eight patients home intact, against one reaction that healed itself before anyone had to explain it. That's the ledger the directorate wants you reading.

So read the other one. Earth's longevity therapy board has now refused the directorate's dataset three times — thousands of patients tracked over years — and maintains formal unresolved objections. The directorate's answer was to mail forty-one pages with nine cut out. "A partial record is not a partial answer," said one board reviewer, who asked not to be named because the objections remain formal. "It is a decision about what we are allowed to know."

Who decides which nine pages stay dark? Who benefits when a fever's cause gets filed under redaction instead of diagnosis? And who signed off on selling the last charter berth the same afternoon the file came out?

The directorate's medical chair, Dr. Halvorsen Adé, calls the seal mercy. "We protect the patient before we protect the program," the chair said. "An engineer's medical file is not a public referendum on our sovereignty." Asked why nine pages needed protecting when the other forty-one didn't, the chair said the redactions were "identifying, not clinical."

Earthside isn't buying the arithmetic. The therapy board's position is that a clean second cohort proves the protocol repeats, not that it's safe, and that repeatability sold as therapy is what a population-scale experiment looks like from the inside. The board's chair, Dr. Imre Vale, put the sovereignty question plainly: "We are asked to certify a treatment we have never been permitted to examine. That is not caution. That is a locked door with a waiting room behind it."

Meridian's answer is that the door is its own to lock. A colony that wrote its own founding charter, the argument goes, does not owe Earth a dataset because Earth would like one. And Earthside 'safety,' in this telling, is a cartel guarding its own frozen waitlists.

Both things can be true at once. The desperate aren't waiting around to find out which. The third charter is full. The transfer calendar has become health policy by default. And nine pages sit in the dark while one hundred and thirty-nine people count down sixty-one days to a crossing they've already paid for.